These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


195 related items for PubMed ID: 8669893

  • 1. Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6.
    Reymen D, Naesens L, Balzarini J, Holý A, Dvoráková H, De Clercq E.
    Antiviral Res; 1995 Dec; 28(4):343-57. PubMed ID: 8669893
    [Abstract] [Full Text] [Related]

  • 2. In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir?
    Andrei G, De Clercq E, Snoeck R.
    Antiviral Res; 2004 Mar; 61(3):181-7. PubMed ID: 15168799
    [Abstract] [Full Text] [Related]

  • 3. [Recent advances in antiviral drugs--antiviral agents to HCMV, HHV-6, and HHV-7].
    Takahashi K.
    Nihon Rinsho; 1998 Jan; 56(1):140-4. PubMed ID: 9465679
    [Abstract] [Full Text] [Related]

  • 4. Susceptibility of human herpesvirus 6 to antiviral compounds by flow cytometry analysis.
    Manichanh C, Grenot P, Gautheret-Dejean A, Debré P, Huraux JM, Agut H.
    Cytometry; 2000 Jun 01; 40(2):135-40. PubMed ID: 10805933
    [Abstract] [Full Text] [Related]

  • 5. Determination of antiviral efficacy against lymphotropic herpesviruses utilizing flow cytometry.
    Long MC, Bidanset DJ, Williams SL, Kushner NL, Kern ER.
    Antiviral Res; 2003 Apr 01; 58(2):149-57. PubMed ID: 12742575
    [Abstract] [Full Text] [Related]

  • 6. Antiviral activities of nucleosides and nucleotides against wild-type and drug-resistant strains of murine cytomegalovirus.
    Smee DF, Barnett BB, Sidwell RW, Reist EJ, Holy A.
    Antiviral Res; 1995 Jan 01; 26(1):1-9. PubMed ID: 7741517
    [Abstract] [Full Text] [Related]

  • 7. Antiviral drug susceptibility of human herpesvirus 8.
    Neyts J, De Clercq E.
    Antimicrob Agents Chemother; 1997 Dec 01; 41(12):2754-6. PubMed ID: 9420052
    [Abstract] [Full Text] [Related]

  • 8. A method for detection of HHV-6 antigens and its use for evaluating antiviral drugs.
    Yoshida M, Yamada M, Chatterjee S, Lakeman F, Nii S, Whitley RJ.
    J Virol Methods; 1996 Apr 26; 58(1-2):137-43. PubMed ID: 8783159
    [Abstract] [Full Text] [Related]

  • 9. Patterns of resistance and sensitivity to antiviral compounds of drug-resistant strains of human cytomegalovirus selected in vitro.
    Snoeck R, Andrei G, De Clercq E.
    Eur J Clin Microbiol Infect Dis; 1996 Jul 26; 15(7):574-9. PubMed ID: 8874075
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Selective activity of various antiviral compounds against HHV-7 infection.
    Zhang Y, Schols D, De Clercq E.
    Antiviral Res; 1999 Aug 26; 43(1):23-35. PubMed ID: 10480261
    [Abstract] [Full Text] [Related]

  • 14. Comparative activity of selected antiviral compounds against clinical isolates of varicella-zoster virus.
    Andrei G, Snoeck R, Reymen D, Liesnard C, Goubau P, Desmyter J, De Clercq E.
    Eur J Clin Microbiol Infect Dis; 1995 Apr 26; 14(4):318-29. PubMed ID: 7649195
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Metabolic diversity and antiviral activities of acyclic nucleoside phosphonates.
    Aduma P, Connelly MC, Srinivas RV, Fridland A.
    Mol Pharmacol; 1995 Apr 26; 47(4):816-22. PubMed ID: 7723743
    [Abstract] [Full Text] [Related]

  • 18. Chemotherapy of the acquired immune deficiency syndrome (AIDS): acyclic nucleoside phosphonate analogues.
    De Clercq E.
    Int J Immunopharmacol; 1991 Apr 26; 13 Suppl 1():91-8. PubMed ID: 1823910
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inhibition of the in vitro growth of Plasmodium falciparum by acyclic nucleoside phosphonates.
    Smeijsters LJ, Franssen FF, Naesens L, de Vries E, Holý A, Balzarini J, de Clercq E, Overdulve JP.
    Int J Antimicrob Agents; 1999 Jun 26; 12(1):53-61. PubMed ID: 10389648
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.